Literature DB >> 12226049

Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis.

Jaume Ferrer1, Juan F Montes, Maria A Villarino, Richard W Light, José García-Valero.   

Abstract

BACKGROUND: Cases of acute respiratory failure reported after talc pleurodesis have raised concerns about its safety. It has been speculated that this pulmonary inflammatory syndrome is secondary to the extrapleural dissemination of the talc particles. STUDY
OBJECTIVES: To test the hypothesis that particle size influences extrapleural talc deposition and pleural inflammation after talc slurry pleurodesis.
DESIGN: Thirty rabbits underwent pleurodesis as follows: 10 rabbits received 200 mg/kg of the talc used for human pleurodesis, normal talc (NT); 10 rabbits received 200 mg/kg of talc with particles of larger size, large talc (LT); and 10 rabbits received saline solution. Samples from the ipsilateral lung, chest wall, diaphragm, mediastinal pleura, heart, liver, spleen, and right kidney were obtained at 24 h and 7 days and processed for optic and electron microscopy and energy-dispersive x-ray analysis.
RESULTS: Visceral pleural thickening was greater with NT than with LT, but no differences were observed in the macroscopic score of adhesions. There was more talc in the lungs of the rabbits that received NT than in those that received LT. Talc particles were detected in mediastinum (100%) and pericardium (20%), irrespective of the talc used. Three animals, all receiving NT, had talc particles in the liver.
CONCLUSIONS: Our study shows that while both talcs were equally effective in achieving pleurodesis, the intrapleural injection of NT elicits greater pulmonary and systemic talc particle deposition than LT. Moreover, pleural inflammation was greater with NT than with LT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226049     DOI: 10.1378/chest.122.3.1018

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Experimental validation of talc pleurodesis for carcinomatous pleuritis in an animal model.

Authors:  Yasunori Iwasaki; Shinzo Takamori; Masahiro Mitsuoka; Masaki Kashihara; Tatsuya Nishi; Daigo Murakami; Ryoichi Matsumoto; Hiroharu Mifune; Yuji Tajiri; Yoshito Akagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-12

Review 2.  Persistent air leaks: a review with an emphasis on bronchoscopic management.

Authors:  Donald R Lazarus; Roberto F Casal
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

4.  Chemical pleurodesis with Viscum album L. extract for secondary spontaneous pneumothorax in elderly patients.

Authors:  Jong Duk Kim; Jae Won Choi; Hyun Oh Park; Chung Eun Lee; In Seok Jang; Jun Young Choi; Dong Hoon Kang; Jae Jun Jung; Jun Ho Yang; Sung Ho Moon; Joung Hun Byun; Sung Hwan Kim; Jong Woo Kim
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

5.  Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak.

Authors:  Takuya Watanabe; Ichiro Fukai; Katsuhiro Okuda; Satoru Moriyama; Hiroshi Haneda; Osamu Kawano; Keisuke Yokota; Masayuki Shitara; Tsutomu Tatematsu; Tadashi Sakane; Risa Oda; Ryoichi Nakanishi
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

6.  Comparison of side effects of oxytetracycline and talc pleurodesis: an experimental study.

Authors:  Alper Gözübüyük; Berkant Ozpolat; Ali Fuat Ciçek; Hasan Caylak; Orhan Yücel; Kuthan Kavaklı; Sedat Gürkök; Onur Genç
Journal:  J Cardiothorac Surg       Date:  2010-12-13       Impact factor: 1.637

7.  Prevention of pleural adhesions by bioactive polypeptides - a pilot study.

Authors:  D Åkerberg; M Posaric-Bauden; K Isaksson; R Andersson; B Tingstedt
Journal:  Int J Med Sci       Date:  2013-10-08       Impact factor: 3.738

8.  Interpretation of expert consensus 2014 on diagnosis and treatment of malignant pleural effusion.

Authors:  Cheng-Ping Hu
Journal:  J Transl Int Med       Date:  2015-03-30

9.  Hemoptysis following Talc Pleurodesis in a Pneumothorax Patient.

Authors:  Yusuke Kakiuchi; Fumihiro Yamaguchi; Makoto Hayashi; Yusuke Shikama
Journal:  Case Rep Pulmonol       Date:  2017-10-16

Review 10.  Diagnosis and Management of Malignant Pleural Effusion: A Decade in Review.

Authors:  Blake Jacobs; Ghias Sheikh; Houssein A Youness; Jean I Keddissi; Tony Abdo
Journal:  Diagnostics (Basel)       Date:  2022-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.